PMID- 23041626 OWN - NLM STAT- MEDLINE DCOM- 20130115 LR - 20220224 IS - 1558-8238 (Electronic) IS - 0021-9738 (Print) IS - 0021-9738 (Linking) VI - 122 IP - 11 DP - 2012 Nov TI - Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. PG - 3955-9 LID - 63113 [pii] LID - 10.1172/JCI63113 [doi] AB - Progranulin (PGRN) is a widely expressed secreted protein that is linked to inflammation. In humans, PGRN haploinsufficiency is a major inherited cause of frontotemporal dementia (FTD), but how PGRN deficiency causes neurodegeneration is unknown. Here we show that loss of PGRN results in increased neuron loss in response to injury in the CNS. When exposed acutely to 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydrophine (MPTP), mice lacking PGRN (Grn(-)/(-)) showed more neuron loss and increased microgliosis compared with wild-type mice. The exacerbated neuron loss was due not to selective vulnerability of Grn(-)/(-) neurons to MPTP, but rather to an increased microglial inflammatory response. Consistent with this, conditional mutants lacking PGRN in microglia exhibited MPTP-induced phenotypes similar to Grn(-)/(-) mice. Selective depletion of PGRN from microglia in mixed cortical cultures resulted in increased death of wild-type neurons in the absence of injury. Furthermore, Grn(-)/(-) microglia treated with LPS/IFN-gamma exhibited an amplified inflammatory response, and conditioned media from these microglia promoted death of cultured neurons. Our results indicate that PGRN deficiency leads to dysregulated microglial activation and thereby contributes to increased neuron loss with injury. These findings suggest that PGRN deficiency may cause increased neuron loss in other forms of CNS injury accompanied by neuroinflammation. FAU - Martens, Lauren Herl AU - Martens LH AD - Gladstone Institute of Cardiovascular Disease, San Francisco, California 94158, USA. FAU - Zhang, Jiasheng AU - Zhang J FAU - Barmada, Sami J AU - Barmada SJ FAU - Zhou, Ping AU - Zhou P FAU - Kamiya, Sherry AU - Kamiya S FAU - Sun, Binggui AU - Sun B FAU - Min, Sang-Won AU - Min SW FAU - Gan, Li AU - Gan L FAU - Finkbeiner, Steven AU - Finkbeiner S FAU - Huang, Eric J AU - Huang EJ FAU - Farese, Robert V Jr AU - Farese RV Jr LA - eng GR - P50 AG023501/AG/NIA NIH HHS/United States GR - I01 BX001108/BX/BLRD VA/United States GR - GMO 100909/PHS HHS/ GR - RR18928/RR/NCRR NIH HHS/United States GR - K08 NS072233/NS/NINDS NIH HHS/United States GR - P01 AG022074/AG/NIA NIH HHS/United States GR - F31 AG034793/AG/NIA NIH HHS/United States GR - C06 RR018928/RR/NCRR NIH HHS/United States GR - R01 AG036884/AG/NIA NIH HHS/United States GR - R01 NS039074/NS/NINDS NIH HHS/United States GR - R01 AG030207/AG/NIA NIH HHS/United States GR - K26 OD010927/OD/NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20121008 PL - United States TA - J Clin Invest JT - The Journal of clinical investigation JID - 7802877 RN - 0 (Granulins) RN - 0 (Grn protein, mouse) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Lipopolysaccharides) RN - 0 (Nerve Tissue Proteins) RN - 0 (Neurotoxins) RN - 0 (Progranulins) RN - 82115-62-6 (Interferon-gamma) RN - 9P21XSP91P (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine) SB - IM EIN - J Clin Invest. 2022 Jan 4;132(1):. PMID: 34981791 MH - 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/*adverse effects/pharmacology MH - Animals MH - Cell Death/drug effects/genetics MH - Cells, Cultured MH - Cerebral Cortex/metabolism/pathology MH - Frontotemporal Dementia/genetics/metabolism/pathology MH - Granulins MH - Humans MH - Inflammation/chemically induced/genetics/metabolism/pathology MH - Intercellular Signaling Peptides and Proteins/genetics/*metabolism MH - Interferon-gamma/pharmacology MH - Lipopolysaccharides/pharmacology MH - MPTP Poisoning/genetics/*metabolism/pathology MH - Mice MH - Mice, Knockout MH - Microglia/*metabolism/pathology MH - Nerve Tissue Proteins/genetics/*metabolism MH - Neurons/*metabolism/pathology MH - Neurotoxins/*adverse effects/pharmacology MH - Progranulins PMC - PMC3484443 EDAT- 2012/10/09 06:00 MHDA- 2013/01/16 06:00 PMCR- 2012/10/08 CRDT- 2012/10/09 06:00 PHST- 2012/01/30 00:00 [received] PHST- 2012/08/17 00:00 [accepted] PHST- 2012/10/09 06:00 [entrez] PHST- 2012/10/09 06:00 [pubmed] PHST- 2013/01/16 06:00 [medline] PHST- 2012/10/08 00:00 [pmc-release] AID - 63113 [pii] AID - 10.1172/JCI63113 [doi] PST - ppublish SO - J Clin Invest. 2012 Nov;122(11):3955-9. doi: 10.1172/JCI63113. Epub 2012 Oct 8.